Labeling of Cautionary Note under Rule of 97 of Drug & Cosmetic Act – (No. DCGI/MISC/572012)
Rule 97 of Drug & Cosmetics Act 1945, provides for printing caution/ Warning in respect of drugs covered under Schedule H, Schedule G and substance covered under the purview of Narcotic & Psychotropic drugs Act, 1985 for the information of patients, doctors pharmacists and others so that there is no misuse of these drugs. It is observed that the caution does not appear in conspicuous manner on the innermost label of these drugs. This leads to unethical use of these medicines by the patients because of difficulty in reading/noticing the cautionary note provided on the label.
Hence all the manufacturers are requested to provide the caution / warning notice on the label in conspicuous manner to attract the attention.
Recent Posts
How to Manufacture Class A & B Medical Devices in India: State FDA License Guide
A quick guide on the Class A & B Medical Device manufacturing license — covering State FDA rules, Form MD-3/MD-5, fees, and timelines for manufacturers. Every manufacturer entering India’s..
Importing Small Quantities of Cosmetics for R&D in India: NOC Requirements
A brief guide on Cosmetic import NOC India — covering when small quantity Cosmetic import for R&D testing bypasses full registration under Cosmetic rules 2020. Not every Cosmetic shipment into I..
The Cosmeceuticals Grey Zone: When a Cosmetic Claim Risks Becoming a Drug Claim
“Cosmeceutical” is a popular marketing word. It suggests something more powerful than an ordinary Cosmetic — a product that treats skin condition, not just improves appearance. The problem is th..
Get In Touch With Our Team
-
Email: contact@cliniexperts.com
-
Timings: 9 am to 6 pm (Monday to Friday)
-
Location: India: Delhi, Bangalore Global: USA, Singapore